论文部分内容阅读
该文分析了64例支气管哮喘患者自初次发病后的治疗措施,发现规范应用吸入糖皮质激素为主、发作时加用解痉平喘药物治疗者仅3例,占4.7%,而长时间全身使用糖皮质激素、长期应用抗生素、单一应用解痉药物等不规范治疗者61例,竟达95.3%。这表明,哮喘发病机制的最新概念以及诊断、治疗、预防等方面新的进展,还未被各级医师所掌握。
This article analyzes 64 cases of patients with bronchial asthma since the initial onset of treatment measures and found that the standard application of inhaled corticosteroids, seizures plus anti-spasmodic drug treatment only 3 cases, accounting for 4.7%, while the long-term systemic The use of corticosteroids, long-term use of antibiotics, single application of antispasmodic drugs and other non-standard treatment in 61 cases, as much as 95.3%. This shows that the newest concepts of the pathogenesis of asthma and new advances in diagnosis, treatment and prevention have not yet been mastered by doctors at all levels.